China Tian Yuan Healthcare Group Limited (0557.HK)

China Tian Yuan Healthcare Group Limited (0557.HK) — VMCI valuation read

0557.HK screens at VMCI 37/100, a 13-point gap below the Consumer Cyclical sector median (50). For a mid-cap China Tian Yuan Healthcare Group Limited share, that placement says the multi-pillar composite is richer or lower quality than the typical peer on a like-for-like basis.

0557.HK has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.

**Investor frame.** Value: 0557.HK trades at 16.0x earnings, 11% below the Consumer Cyclical median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Consumer Cyclical group. Quality: ROIC of 16.0% sits 6.0pp above the Consumer Cyclical median (10.0%), the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of -0.7x leaves covenant headroom, which sets the rate-cycle exposure for China Tian Yuan Healthcare Group Limited.

0557.HK rose 2.8% over the trailing 7 days, with a -6.8% read on a 30-day basis.